Sean Brady's approach to finding and studying drug candidates has identified new types of antibiotics. With better gene sequencing technologies the promise of improved AI modeling, Brady says what he’s found thus far is just the tip of the iceberg. 🔗: https://bit.ly/4ggBc4L

This #AlzheimersandBrainAwarenessMonth we’re highlighting Rockefeller’s Nathaniel Heintz, whose work has helped identify abnormal pathways that feed into the plaques and tangles of Alzheimer's, which may help stop the disease before these pathologies develop.

Chris Giuliano of the Birsoy lab has been selected as a 2026 #JCCFellow by @jcchildsfund.bsky.social#JCCFellow Giuliano studies how microbes share and trade nutrients to help reveal novel ways to treat cancer. Congratulations, Chris!

Rockefeller's Winrich Freiwald is a 2026 winner of the Gertrud Reemtsma Foundation’s Prize for Translational Neuroscience! He is honored for his work deciphering complex neural processes in visual perception and social cognition. Congratulations!

Tremendously excited to announce that I will be joining @rockefeller.edu as an Assistant Professor and Head of Lab starting in January 2027! My group will be broadly focused on theoretical neuroscience, and mathematical problems in neural computation in the large.

A new protein-tracing platform from Rockefeller's Ekaterina Vinogradova and Paul Cohen in @cellpress.bsky.social reveals how fat and liver cells communicate during fasting, inflammation, and obesity, and links many of those signals to human disease. 🔗: https://bit.ly/4uOU9ik

Alexander Lercher of Rockefeller's Rice lab studies how fighting off one virus changes the way the immune system responds to a totally unrelated one. His work is uncovering immune pathways that let our bodies adapt to viral threats over time. 🔗: https://bit.ly/43GfYWw

Rockefeller's @steve-bonilla.bsky.social has been named a 2026 scholar by @pew.org! Steve is recognized for his work investigating how RNA molecules fold into three-dimensional structures to drive complex biological processes. Congratulations!

A new study from Hermann Steller and colleagues identifies genetic mutations that interfere with the body’s ability to degrade the protein clumps characteristic of neurodegenerative diseases like Parkinson’s and Alzheimer’s. 🔗: https://bit.ly/4oC4AEI

Last month, Rockefeller's Women & Science initiative held its annual spring event featuring our very own Vanessa Ruta, where she spoke about her pioneering research deciphering how smell works.

In @ScienceAdvances: Findings from Rockefeller's #MacKinnonLab suggest that Piezo1 ion channels are activated by a specific membrane-derived cofactor that complements mechanical force. These channels help cells respond rapidly to mechanical cues.

The @victora.bsky.social lab at Rockefeller has turned germinal centers into a living laboratory for one of biology's oldest questions: how much of #evolution is shaped by chance? Learn more in this Q&A with Victora and graduate fellow Ashni Vora: https://bit.ly/4fB23bm

Congratulations to Lucas Tian, recipient of the 2026 Tri-I Breakout Award! Lucas is being recognized for pioneering research that explores one of the most fundamental questions in neuroscience: how the brain uses existing knowledge to solve entirely new problems.

A new study from Rockefeller's @victora.bsky.social in @cellpress.bsky.social reveals how germinal centers produce powerful antibodies through noisy rounds of mutation and selection, offering new insight into vaccine design—and larger themes in evolution. 🔗: https://bit.ly/3Sor6Ve

Congratulations to Rockefeller’s #classof2026, here’s to your next adventure! 🍾 🔬 🎉 #PHDone

How can a brain no bigger than a poppy seed offer insights into the mechanisms by which humans navigate the world and make choices? Rockefeller's Gaby Maimon addresses this question, and more, in a #SeekMagazine interview: https://bit.ly/4ogZv4n

A new study from the @rocklabtb.bsky.social in @natmicrobiol.nature.com finds that one of the most common drug resistance mutations in #tuberculosis creates subtle metabolic weaknesses that could be exploited with future combination therapies. 🔗: https://bit.ly/3RG6wj2

This #SkinCancerAwarenessMonth, we’re highlighting Rockefeller's Elaine Fuchs, who has spent decades studying skin stem cells and what happens when they turn dysfunctional. Her work has shed light on how they can become the seeds of cancer or chronic inflammation.

2026 marks a major milestone for Rockefeller: 125 years ago, the university was founded as the Rockefeller Research Institute. In this in-depth Q&A, President Rick Lifton discusses the enduring power of our guiding mission. #125YearsofRockefeller 🔗: https://bit.ly/3RAUzeq

The transition from undergraduate science to professional research can be daunting. Rockefeller's Research Assistant Association is designed to build community and skills among its early-career scientists. 🔗: https://bit.ly/4tVe278

In @nature.com: Winrich Freiwald's lab has discovered the first evidence of the neural substrates that underlie the basic units of thought. The findings have implications for improving computer-brain interfaces and studying brain disorders. 🔗: https://bit.ly/4dvTzkt

Rockefeller scientists are studying the molecular machines that read, copy, repair, and package DNA. Their findings could change how we prevent and treat diseases, including cancer. Learn more in #SeekMagazine: https://bit.ly/3RmAvfC

Rockefeller's Lamia Wahba studies how information outside the genetic code—epigenetic signals—can pass between generations and what that means for evolution and disease. We spoke to Wahba about how this work could reshape our understanding of heredity: https://bit.ly/4tC29CO

Two techniques from Rockefeller's Junyue Cao—one for optics-free spatial mapping of tissue organization and the other for the enrichment of rare cell types—offer new ways to study aging and disease. 🔗: https://bit.ly/4u8CLpq

A new study in @natmicrobiol.nature.com from Rockefeller's Paul Bieniasz and Theodora Hatziioannou shows the most comprehensive view to date of how some HIV-1 strains develop drug resistance to broadly neutralizing antibodies. 🔗: https://bit.ly/42MYbfT

Herbert Gasser, Rockefeller’s director from 1935 to 1953, discovered that nerves carry different kinds of signals at different speeds, and helped clarify how the nervous system transmits sensation, movement, and pain. In 1944, he shared the @nobelprize.org for this work. #125YearsofRockefeller

Reporter @ellenbarry.bsky.social was searching for answers about what was going on with her father's memory in the final stages of dementia. She turned to Rockefeller's Priya Rajasethupathy. Learn what happened in this piece from @nytimes.com:

Last month, the Nussenzweig lab revealed a new gene editing approach that produces enduring and protective levels of antibodies that have previously been difficult to engineer. The method could offer ways to treat viruses like HIV that can outsmart traditional vaccination approaches.

In @cp-molcell.bsky.social: RNA polymerase, the enzyme that synthesizes RNA from DNA during transcription, has been captured mid-reaction for the first time by scientists in Seth Darst's lab at Rockefeller. 🔗: https://bit.ly/4ur3Vaz

Check out this @science.org paper! Scientists at @rockefeller.edu have discovered that #CRISPR-edited hematopoietic stem cells generate B cells that produce durable, protective antibodies following vaccination. 📄 https://bit.ly/4cJbimv 🎧 https://bit.ly/4vRAGPT

Learn how Rockefeller's Marina Caskey, Michel Nussenzweig and Gabriel Victora are using #BasicScience to build better vaccines in this #SeekMagazine interview: https://bit.ly/4eeE8hc

Jeanne Garbarino, head of RockEDU Science Outreach at Rockefeller, says that persistence in #STEM depends on fostering a culture of high-quality mentoring and long-term engagement. “Students stay in STEM when they feel like they belong.” 🔗: https://bit.ly/424DrQd

Rockefeller's Vanessa Ruta and Thomas Tuschl have been elected to the @nasonline.org! Congratulations 🎉 🔗: https://bit.ly/4vTZgQ8

A new @pnas.org study from the Charles Rice's lab at Rockefeller overturns decades-long assumptions about why the #hepatitis B virus fails to infect mouse liver cells when studying it in an animal model, providing a foundation to develop a much-needed new one. 🔗: https://bit.ly/4sORGDu

This #EarthDay we're featuring Rockefeller's @flamholz.bsky.social#EarthDay who studies how microbes contribute to #climatechange and how they could offer solutions to this problem via their metabolisms.

How do cells convert mechanical information into a molecular process? The @alushinlab.bsky.social has captured the first snapshot of a mechanical signaling complex in action, findings in @nature.com that have implications for disorders related to myosin dysfunction. 🔗: https://bit.ly/41Kshjw

Rockefeller's Shixin Liu is pioneering new ways of studying the tiny proteins that copy and transcribe genetic code. We spoke to Liu about what makes these machines so fascinating and why studying them could shed light on diseases from tuberculosis to cancer: bit.ly/4vGE4gn

In @natcellbio.nature.com: Rockefeller's Birsoy lab has discovered that the antioxidant glutathione plays a vital role in maintaining smooth operations of a protein-producing hub in the cell called the endoplasmic reticulum by acting as a protein “proofreader.” 🔗: https://bit.ly/3Ow8lxM

By editing blood stem cells, the Nussenzweig lab shows that the immune system itself can be transformed into a durable, boostable source of therapeutic proteins--opening the door to potential single-shot treatments for diseases ranging from HIV to cancer. 🔗: https://bit.ly/4cgDoqp

Rockefeller's Margaret Schroeder of the Darnell lab has been named a 2026 #LeonLevyScholar! She is recognized for her work interrogating the molecular underpinnings of local astrocyte-neuron plasticity in health and disease. Congratulations!

A @nature.com study from Rockefeller's @junyuecao.bsky.social describes a new platform called PerturbFate that reveals how diverse genetic perturbations funnel into shared disease states, a method that could unlock therapeutic targets for complex diseases. 🔗: https://bit.ly/4thIsRw

Rockefeller's @danielkronauer.bsky.social comments on new research describing a distinctive partnership between two ant species in which one grooms the other in @nytimes.com:

In 1911, Peyton Rous, a Rockefeller physician, made a discovery with sweeping implications. Viruses can cause cancer. His findings laid the foundation for modern cancer biology. In 1966, Rous won a @nobelprize.org. #125YearsofRockefeller Footage courtesy of NobelPrize.org

Rockefeller scientists, including @danielkronauer.bsky.social, Vanessa Ruta, Winrich Freiwald, Priya Rajasethupathy, and @erichjarvis.bsky.social, are learning what drives social behavior, and also trying to explain what happens when those roots falter. 🔗: https://bit.ly/47J2Q5h

The quieter the sound, the harder your hair bundles work to amplify it. An international team—including members of the Hudspeth lab at Rockefeller—shows that hair bundles sense, amplify, dissipate heat, or even act as tiny refrigerators.

Three years in, the Stavros Niarchos Foundation Institute for Global Infectious Disease Research has matured into a working pipeline connecting basic science and emerging therapies:

Researchers in Charles Rice's lab at Rockefeller have created the first mouse model that closely mirrors what happens when people with hepatitis C develop liver cancer, allowing scientists to study how liver virus infection leads to cancer as well as to test treatments. 🔗: https://bit.ly/4dCzhGp

The NPC is far more than a molecular gate. “It’s a nexus for integration of information,” Rockefeller's Mike Rout says. “And I think if the cell had thoughts, that would be how it thinks of its nuclear pores.” In @quantamagazine.bsky.social, by @yaseminsaplakoglu.bsky.social:

In 1928, Rebecca Lancefield discovered the M protein, the key to understanding how Streptococci-related diseases are acquired and spread. Over the next six decades, she classified thousands of strep strains. The Lancefield Grouping is still used today. #125YearsofRockefeller

Rockefeller's Jeff Friedman has been named a #Forbes250 Greatest Innovator! @forbes.com#Forbes250recognizes Friedman for his discovery of the weight-regulating hormone leptin, ushering in a new medical era. Congratulations, Jeff!